Utah Retirement Systems Cure Vac N.V. Transaction History

Utah Retirement Systems

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$14.73 - $35.25 $141,408 - $338,400	-9,600 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$49.26 - $74.5 $24,630 - $37,250	-500 Reduced 4.95%	9,600 $524,000
Q2 2021 Aug 16, 2021	SELL	$56.91 - $127.53 $147,966 - $331,578	-2,600 Reduced 20.47%	10,100 $742,000
Q1 2021 May 17, 2021	BUY	$79.79 - $126.29 $1.01 Million - $1.6 Million	12,700 New	12,700 $1.16 Million

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $499M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

Stay updated on Utah Retirement Systems with notifications on news.